Granite Bay Wealth Management »

Crispr Therapeutics shares owned by Granite Bay Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Granite Bay Wealth Management from 13F filings

Historical chart of Granite Bay Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Granite Bay Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Granite Bay Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 41k 57.79
2023-12-31 $1.2M 20k 57.70
2023-09-30 $843k 16k 51.66

More positions owned by Granite Bay Wealth Management

John Hancock Exchange Traded Multifactor Mi (JHMM)
John Hancock Exchange Traded Corporate Bd (JHCB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Msci Jpn Etf New (EWJ)
John Hancock Exchange Traded Preferred Income (JHPI)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares Advantag (BALI)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Granite Bay Wealth Management

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics